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Abstract. Expression of the mosXe protein kinase is re-
quired for the normal meiotic maturation of Xenopus
oocytes and overexpression induces maturation in the
absence of other stimuli. In addition, mosXe functions
as a component of cytostatic factor (CSF), an activity
responsible forarrest ofthe mature egg at metaphase II.
After microinjection of Xenopus oocytes with in vi-
tro synthesized RNA encoding either wild-type mosXe
or kinase-inactive mos-(R9°) , both proteins are phos-
phorylated exclusively on serine residues and exhibit
essentially identical chymotryptic maps. Since the
phosphorylated kinase-inactive mosXe1R9o1 protein was
recovered from resting oocytes that have not yet be-
gun to translate endogenous mosXe , this indicates that
the major phosphopeptides of mos*R9°1 are phosphory-
lated by a preexisting protein kinase present in resting
oocytes, and are not the result of autophosphorylation.
The results presented here also indicate that the mosXe
protein does not undergo significant phosphorylation at
unique sites during oocyte maturation.
If the biological activity of mosXe were regulated by
T
HE reversiblephosphorylationofproteinsisakeyregu-
latory mechanism involved in biological processes
such as growth factor signal transduction and cell cy-
cle control. The consequences ofinappropriate phosphory-
lation are exemplified by the many oncogenes that encode
protein kinases (for reviews see Hunter and Cooper, 1986;
Cantleyet al., 1991; Hunter, 1991; Freeman andDonoghue,
1991). The v-mos oncogeneanditscellularhomolog, c-mos,
encode proteins with intrinsic serine/threonine protein ki-
nase activity (Maxwell andArlinghaus, 1985; Hanninkand
Donoghue, 1985 ; Singh et al., 1986; Yew et al., 1991).
Several observations demonstrate that the protein kinase
encodedby the Xenopus c-mos gene (mosXe)plays an obliga-
tory role in the meiotic maturation of oocytes. By blocking
R. S. Freeman's present address is Department of Pharmacology, Washing-
ton University School of Medicine, St. Louis, MO 63110.
© The Rockefeller University Press, 0021-9525/92/02/725/11 $2.00
The Journal of Cell Biology, Volume 116, Number 3, February 1992 725-735
phosphorylation, a site of regulatory phosphorylation
would most likely be conserved among mos proteins
ofdifferent species. Site-directed mutagenesis was
used to construct 13 individual serine-alanine muta-
tions at conserved residues (3, 16, 18, 25, 26, 57, 71,
76, 102, 105, 127, 211, and 258). These 13 mutants
were analyzed for their abilities to induce oocyte matu-
ration and to function as CSR Results obtained with
the MOs-(^'°51 mutant revealed that serine-105 is re-
quired for both maturation induction and CSF activity,
even though serine-105 does not represent a major site
ofphosphorylation. All ofthe remaining serine-ala-
nine mosXe mutants induced oocyte maturation and ex-
hibited CSF activity comparable with the wild type.
These results demonstrate that none ofthe conserved
serines examined in this study function as regulatory
phosphorylation sites for these biological activities.
Peptide mapping of the remaining mosXe mutants
identified serine-3 as a major phosphorylation site in
vivo, which is contained within the chymotryptic pep-
tide MPSPIPVERF.
synthesis of the mosXe protein with antisense oligonucleo-
tides, Sagata et al. (1988) showed that expression of mosXe
was required for normal oocyte maturation induced by
progesterone. Otherexperimentsdemonstrated that microin-
jection of in vitro synthesized mosXe RNA into immature
oocytes couldinduce maturationin theabsence ofprogester-
one(Freemanet al., 1989;Sagataetal., 1989a). Translation
ofmosisalso requiredforprogressionfrommeiosisI tomei-
osis II, both in murine oocytes (O'Keefe et al., 1989) and
also Xenopusoocytes (Kanki and Donoghue, 1991). Further-
more, the mosXe protein constitutes an essential component
of cytostatic factor (CSF)' (Watanabe et al., 1989; Sagata
etal., 1989b), which is responsibleformaintaining unfertil-
1. Abbreviations used in this paper: CSF, cytostatic factor; GVBD, germi-
nal vesicle breakdown; MBS-H, modified Barth's solution.
725ized eggs in a state of metaphase II arrest (Meyerhof and
Masui, 1979).
Xenopus oocyte maturation is accompanied by a two- to
threefold increase in protein phosphorylation (Maller et al.,
1977). Recently, several protein kinases have been shown to
be activated during maturation. For example, the p34,d~2 ki-
nase (Gautier et al ., 1989; Dunphy and Newport, 1989), S6
kinase (Erikson et al., 1987), and microtubule-associated
protein kinase (Gotoh et al., 1991) increase in activity during
maturation. Moreover, each of these enzymes is itself regu-
lated by phosphorylation by other protein kinases. Phos-
phorylation of p34,d z occurs on threonine and tyrosine
residues and appears to exert both activating and inhibitory
effects on its kinase activity (Dunphy and Newport, 1989;
Gautier et al., 1989; Gould and Nurse, 1989 ; Labbe et al.,
1989; Morla et al., 1989 ; Solomon et al., 1990; Lee et
al ., 1991). S6 kinase II is known to be activated via phos-
phorylation by microtubule-associated protein kinase in vitro
(Sturgill et al., 1988), and phosphorylation of threonine and
tyrosine residues in microtubule-associated protein kinase
correlates with its activation in vivo (Ray and Sturgill, 1988;
Anderson et al ., 1990) .
The mosx° protein kinase induces oocyte maturation
through an unknown mechanism that involves the activation
of maturation promoting factor (Sagata et al., 1989a; Free-
man et al ., 1991). Activation of maturation promoting factor
is known to involve changes in the phosphorylation state of
its two subunits, the p34cdc2 protein kinase and the cyclin B
proteins (for review see Pines and Hunter, 1990; Maller,
1990; Freeman and Donoghue, 1991). The mosx° protein it-
self undergoes phosphorylation during oocyte maturation
(Sagata et al., 1988 ; Watanabe et al., 1989) . In addition, the
kinase activity of the mosx° protein is required for both
maturation-promoting activity and CSF activity as demon-
strated by the absence of these activities in the kinase-
inactive mutant mosxe(R9°), in which the lysine residue in the
ATP binding site has been substituted with arginine (Free-
man et al., 1989, 1990). Hyperphosphorylated forms of the
mosx° protein have been observed in mature eggs (Watanabe
et al., 1989 ; Sagata et al., 1989b), and dephosphorylation
of mosx° was recently shown to precede the degradation of
move that occurs shortly after egg activation (Watanabe et
al., 1991) .
In this work we have used peptide mapping to characterize
the phosphorylation state of the mos- protein. In addition to
examining the wild-type mosx° and kinase-inactive mos-(R90)
proteins, we have also examined 13 individual serine-ala-
nine mutants affecting potential phosphorylation sites. Our
results suggest that the mosx° protein does not undergo sig-
nificant phosphorylation at unique sitesduring oocyte matu-
ration. Moreover, our results demonstrate that none of the
conserved serines examined in this study function as regula-
tory phosphorylation sites for either the induction of oocyte
maturation or its ability to function as CSF Peptide mapping
of the various serine-alanine mosx° mutants also identified
serine-3 as a major phosphorylation site in vivo.
Materials andMethods
Microinjection ofRNA and Metabolic Labeling
ofXenopus Oocytes
Fully grown (stage VI) oocytes were manually dissected from the ovaries
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of female Xenopus (obtained from Xenopus I, Ann Arbor, MI) and in-
cubated at 18°C in modified Barth's solution (MBS-H; 10 mM Hepes, pH
7.4, 88 mM NaCl, 2.4 mM NaHC03, 1 mM KCI, 0.82 mM MgSO4, 0.41
MM CaC12, 0.33 mM Ca[N03]2, 0.1 mg/ml each of penicillin and strep-
tomycin). Healthy oocytes were microinjected with 50 nI of in vitro tran-
scribed RNA (1-2 mg/ml) and then incubated at room temperature in either
MBS-H alone, or MBS-H containing 0.5 mCi/ml [358]cysteine or 20
mCi/ml [32P]orthophosphate. In some experiments, oocytes were labeled
by microinjection with 50 nl of [32P]orthophosphate (150-740 mCi/ml)
(see Fig. 1). Oocytes were scored for germinal vesicle breakdown (GVBD)
by the appearance of a white spot in the pigmented animal pole (Merriam,
1971). Oocytes were fixed in 5% TCA and dissectedto confirm GVBD. For
progesterone treatment, oocytes were incubated in MBS-H containing 15
AM progesterone.
Construction ofmos- Mutants and In Vitro
Tl anscription ofRNA
The pSP64(polyA) vectors (Promega Biotec, Madison, WI) containing the
mosx` coding sequence and the mosx°(a9°) sequence were described else-
where (Freeman et al., 1989) . Site-directed mutagenesis resulting in
ser-ala substitutions at codons 3, 16, 18, 25, 26, 57, 71, 76, 102, 105, 127,
211, and258 was performed as described (Zoller and Smith, 1983; Kunkel,
1985) using oligonucleotides ranging in size from 20 to 26 nucleotides. Re-
striction fragments containing the mutated DNAs were sequenced and then
subcloned into the corresponding region of the wild-type mosx°/pSP64-
(polyA) plasmid. In vitro transcription reactions yielding 5'-capped and
polyadenylated RNAs were carried out as described (Melton, 1987). The
integrity of the RNAs was analyzed by electrophoresis and by in vitro
translation using rabbit reticulocyte lysate (Amersham Corp., Arlington
Heights, IL).
CsFAssays
CSF assays were performed essentially as described previously (Freeman
et al., 1990). Ovulation was induced by injecting frogs with200 IUof preg-
nant mare serum gonadotropin (Calbiochem-Behring Corp., San Diego,
CA) 5-7 d before injection of600IU human chorionic gonadotropin (Sigma
Chemical Co., St. Louis, MO). Eggs were collected into MR solution
(5 mM Hepes, pH 7.8, 100 mM NaCl, 2 mM KCI, 1 MM MgC12.61120,
2 mM CaC12) -12 h after injection with human chorionic gonadotropin
and fertilized in vitro. After the fertilized eggs rotated animal pole up, they
were dejellied in 2 % cysteine and cultured in MR containing 6% Ficoll be-
fore microinjection. Two-cell embryos were microinjected in the animal
pole of one blastomere with 30 nl ofRNA (1-2 mg/ml) just before comple-
tion of the first cleavage.
Immunoprecipitations
Metabolically labeled and 32p-labeled oocytes were rinsed twice in MBS-H
and then transferred to a 1.5-ml tube containing 3-5 /sl/oocyte of ice-cold
lysis buffer (8.5 mM Tris-HCI, pH 6.8, 1% NP-40,150 mM NaCl, 50 mM
0-glycerophosphate, 10 mM NaF, 5 mM EDTA, 2 mM DTT, 2 mM ATP,
2 mM sodium pyrophosphate, 2 mM EGTA, 1 mM Na3VO4, 10 pg/ml
aprotinin, 2 tig/ml leupeptin, 10 pM pepstatin A). Oocytes were manually
lysed, andthe lysates were clarified by centrifugation at 10,000 g for 5 min.
Cytosolic fractions were preadsorbed with 30-80 pl ofa 50% (vol/vol) sus-
pension of protein A-Sepharose/lysis buffer for 25 min at 4°C. After cen-
trifugation in a microfuge for 3-5 min, the supernatants were collected and
incubated with 5-10 pl of COOH-terminal antipeptide serum (and-mosx`
serum) (Freemanet al., 1990) for 2 h at 4°C. Immune complexes were col-
lected with protein A-Sepharose as described above, layered onto 1 nil of
lysis buffercontaining 10% sucrose, and then pelletted for 10 min at 2,500 g.
The pellets were washed two-three times with lysis buffer and analyzed by
15% SDS-PAGE and autoradiography.
Peptide Mapping
Two-dimensional phosphopeptide mapping was performed as described by
others (Hunter and Sefton, 1980). The mosx° proteins were eluted from
acrylamide gels and digested twice, each time with 10 wg ct chymotrypsin
(Worthington Biochemical Corp., Freehold, NJ), for 10-14 h and then
2-4 h. Peptides were separated in the horizontal direction by electrophore-
sis in pH 8.9 buffer (I% ammonium carbonate) for 23 min at 1 kV. Separa-
tion in the vertical direction was by chromatography in a system ofn-butanol,
water, pyridine, and acetic acid (75:60:50:15, [vol/vol]). Phosphoamino
726acid analysis was performed by electrophoresis in two dimensions (pH 1.9
and 3.5) as previously described (Cooper et al ., 1983) .
Secondary protease digestions of chymotryptic phosphopeptides was
performed as follows . Phosphopeptides were recovered from TLC plates
and eluted from the cellulose with a solution of 88% formic acid, acetic
acid, and water (5:16:180, [vol/vol]) . The eluate was then lyophilized and
the dry phosphopeptides were resuspended in 50 mM ammonium bicar-
bonate. Protease digestions were carried out for 4 h at 37°C with 5 ug
praline-specific endopeptidase (ICN Biomedicals, Inc ., Irvine, CA) . The
reaction products were analyzed by electrophoresis and chromatography as
described above.
Results
Phosphorylation ofthe Kinase-inactive mos-(R9°)
Protein Is Indistinguishablefrom that ofthe Wild-Type
mos- Protein
Progesterone treatment of Xenopus oocytes stimulates the
synthesis and phosphorylation of the move protein (Wata-
nabe et al ., 1989) . Matured eggs contain additional phos-
phorylated forms of the mosxe protein that are not present in
maturing oocytes before GVBD (Watanabe et al., 1989 ;
Sagata et al ., 19896 ; data not shown) .
If some of the phosphate on mosxe is the result of auto-
phosphorylation, then a kinase-inactive mutant of mosxe
should lack these phosphorylations . To analyze the extent of
move autophosphorylation, we compared the phosphoryla-
tion pattern of move to that of mosxe(R90), a mutant protein
that contains a lysine-to-arginine substitution in the canoni-
cal ATP-binding domain . The mosxe(R90 protein is biologi-
cally inactive when expressed in oocytes (Freeman et al .,
1989, 1990), and an analogous mutation in the v-mos protein
abolishes its transforming and in vitro kinase activities (Han-
nink and Donoghue, 1985 ; Singh et al ., 1986) .
Endogenous move protein is translated from maternal
mRNA during meiotic maturation and, therefore, exists at
undetectable levels in stageVI oocytes in the absence of hor-
monal stimulation (Sagata et al ., 1989a ; Watanabe et al .,
1989) . Consequently, intermolecular phosphorylation of
MOS xe(R90) protein by endogenous mosxe protein would not be
expected to occur in resting stage VI oocytes.
Both move and MOSxe(R90 proteins were phosphorylated in
microinjected oocytes (Fig . 1 a) ; however, only oocytes in-
jected with wild-type move RNA underwent meiotic matu-
ration . Bothproteins were phosphorylated to a similar extent
during a 1-h labeling period (Fig . 1 a, lanes 1 and 3) . How-
ever, when oocytes were labeled for a longer time (corre-
sponding to the time required for GVBD in 100% of the
wild-type mosxe-injected oocytes) the incorporation of ra-
dioactive phosphate into the wild-type move protein was
much greater than the incorporation into the mosxe(R90 pro-
tein (Fig . 1 a, lanes 2 and 4) . This was probably not because
of a change in the labeling efficiency during maturation
since the pools of orthophosphate and nucleoside triphos-
phates have been shown to vary by <13% during meiotic
maturation (Maller et al ., 1977) . Moreover, this was not be-
cause of an increase in the amount of mosxe protein relative
to mos xe (R90 protein as shown by [3IS]methionine labeling
(data not shown) .
Phosphoamino acid analysis of the mos-(R90 and mosxe
proteins revealed only phosphoserine (Fig . 1 b) . To compare
the phosphorylationpatterns inmore detail, immunoprecipi-
tated mosxe(R90 and mosxe proteins were subjected to proteol-
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Figure 1. Comparison of mos- phosphorylation with that of
MOs-(R90 . (a) Oocytes were microinjected with mos- RNA or
MOs-(R90 RNA, 2 h later, the oocytes were reinjected with [32p]-
orthophosphate (740 1ACl/pl) . Half of the injected oocytes were
lysed 1 h after the [ 32P]orthophosphate injection while the remain-
ing oocytes were lysed after the mos- injected oocytes had under-
goneGVBD (8 h after the [32P]orthophosphate injection) . Immuno-
precipitations were performed with anti-mos- serum and analyzed
by 12 .5% SDS-PAGE and autoradiography with an intensifying
screen for 22 h . (b) The mosxe and MOs-(R90 proteins shown above
(labeled for 8 h) were eluted from the polyacrylamide gel . Phospho-
amino acid analysis was performed and individual phosphoamino
acids were separated by two-dimensional electrophoresis . The loca-
tions of unlabeled phosphoserine (S), phosphothreonine (T), and
phosphotyrosine (Y) are indicated .
ysis with chymotrypsin and the resulting phosphopeptides
were analyzed by two-dimensional phosphopeptide mapping
(Fig. 2) . All of the most highly phosphorylated peptides
were present in both mosxe and mos%e(R90 suggesting thatFigure 2 . Chymotryptic phosphopeptide maps of MOs-1890) and moose . The mos- and MOs-(R9°> proteins described in Fig . 1 (labeled for
8 h) were recovered from the polyacrylamide gel, oxidized with performic acid, and then digested with chymotrypsin . Phosphorylated
peptides were separated on TLC plates by electrophoresis in the horizontal direction and by chromatography in the vertical direction, as
indicated . In the mixed sample, an approximately equal number of cpm from the mutant and wild type were used . x indicates the location
of the origin . Phosphopeptides were detected by autoradiography with an intensifying screen for 9 d .
they were not the result of autophosphorylation . These pep-
tides are designated as chymotryptic peptides No . 1-5, as
shown in the right panel of Fig . 2. The yield of peptide No .
5 was quite variable and usually low, although it is quite evi-
dent on the maps in Fig . 2 .
Although trypsin is more often used for peptide mapping,
our choice of chymotrypsin was influenced by previous pep-
tide mapping experiments of the v-mos protein, in which
chymotrypsin was found to yield superior maps to trypsin
(Papkoff et al ., 1982) .
Mutagenesis ofConserved Serine Residues in mos- :
Effects on Maturation-InducingActivity
There are many examples of protein kinases that are regu-
lated by phosphorylation, and the regulatory phosphoryla-
tion sites are often conserved . A well-studied example is the
effect of phosphorylation on the kinase activity of the mem-
bers ofthe src family oftyrosine protein kinases (Hunter and
Cooper, 1986) . Another example is the conservation of a
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Figure 3. Location of the 13 most highly conserved serines in moss° . Serines 3, 16, 18, 25, 26, 57, 71, 76, 102, 105, 127, 211, and 258
in mos- were individually mutated to alanines by site-directed mutagenesis. The linear position of each of these residues is depicted in
the Xenopus, chicken, human, and mouse mos proteins . For each sequence, the presence of a conserved serine is indicated by a vertical
bar. These represent all serine residues that are conserved in at least three of the four species shown. Note that serines 26, 71, and 76
are present in only three species ; the other serine residues areconserved among all four species . The locations ofsequence motifs character-
istic of protein kinases are shown at the bottom . (Amino acids indicated by single letter abbreviations .)
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tyrosine residue in p34c°c2 , that when phosphorylated in-
hibits kinase activity (Gould and Nurse, 1989) . Since the
mos proteins from several different species (Xenopus, hu-
man, mouse, and chicken) can all function to induce Xeno-
pus oocyte maturation (Yew et al., 1991), we hypothesized
that some of the biologically significant phosphorylation
sites might be conserved .
In the mosse protein, there are 10-serine residues (S3,
S16, S18, S25, S57, S102, 5105, S127, S211, and S258) that
are also conserved in the human, mouse, and chicken mos
proteins (Fig . 3) . To analyze the importance of these
residues, we individually mutated the codon for each con-
served serine to an alanine codon . We also constructed three
additional serine-alanine mutations in mos- at positions
where the serine was present in three out of four,species of
mos protein (S26, S71, and S76) . To examine these mutants
for biological activity, in vitro synthesizedRNA encoding ei-
ther a mutant mos- protein or the wild-type protein was
microinjected into stage VI Xenopus oocytes (Table I) . The
injected oocytes were then monitored forGVBD. In these ex-
211
￿
258Table L Biological Activity and Phosphopeptide Pattern
ofmos- e ser-ala Mutants
(GVBD assays) Oocytes were microinjected with 50 nl (1-2 mg/ml) of in vitro
synthesized RNA encoding either the wild-type mos- protein or one of the 13
serala mosxe mutants . GVBD was scored by the appearance of a white spot
at the animal pole and confirmed by fixation with 5% TCA and manual dissec-
tion . (CSFactivity) One blastomere ofcleaving two-cell embryos was injected
with 30 nl (1-2 mg/ml) of in vitro synthesized RNA encoding either the wild-
type mos- protein or one of the 13 serala mos" mutants . For each RNA, 10
fertilized embryos were injected just as the first cleavage furrow was forming,
- 1 .3 h after fertilization . After N4 h, embryos were scored for cleavage arrest
ofthe injected blastomere . A + indicates that atleast 7/10 injected blastomeres
displayed at least partial cleavage arrest, and a - indicates that none ofthe in-
jected blastomeres underwent cleavage arrest . See legend to Fig . 7 for further
details . (Chymotrypticpeptides) Chymotryptic phosphopeptide maps were pre-
pared for each of the serala mutant proteins as described in Materials and
Methods . The peptide maps for each mutant were compared to those of the
wild-type mos" protein .
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periments, 12 of the 13 mutants induced GVBD with an
efficiency and kinetics similar to the wild-type mos- pro-
tein . However, one of the mutants, moS-(^105 )' was unable to
induce GVBD. No sign ofGVBD was detected in any of the
mosxe(A105)-injected oocytes even 6 h after the wild-type
mosxe-injected oocytes reached 100% GVBD. This was not
because ofa dramatically decreased half-life of the mutant
protein, as the mosxe(AI 05) protein was translated and ex-
pressed at the same level as the wild-type mos- protein
during labelings periods of varying duration after microin-
jection (data not shown) .
Serine105 Is Not a Major Site ofPhosphorylation
The mosxe(A 1o5 ) protein is phosphorylated to approximately
the same level as the mosxe protein in pre-GVBD oocytes .
During longer labeling periods, the wild-type protein be-
comes phosphorylated to a greater extent than the mosxe(AI05)
protein (data notshown), becauseofmaturation ofthe wild-
type mosxe-injected oocytes . To compare the phosphoryla-
tion pattern of moSxe(A105) to that of wild-type mosxe, we pre-
pared two-dimensional chymotryptic phosphopeptide maps
of each protein (Fig . 4) . Oocytes were microinjected with ei-
ther mosxe(A105) or mosxe RNA and labeled with ["P)or-
thophosphate until the mosxe-injected oocytes underwent
GVBD . The wild-type and mutant proteins were purified by
immunoprecipitation anddigested with chymotrypsin . Allof
the major phosphopeptides in the wild-type mos- protein
were also present in the mosxe(A 1o5) protein. Thus, under
these conditions, phosphorylation of the mosxe(A105 ) protein
occurs at the same sites as in the wild-type mosxe protein
suggesting that serine-105 is not a significant phosphoryla-
tion site in mosxe .
The chymotryptic peptides No. 1-4 areobserved as in the
Figure 4 . Chymotryptic phosphopeptide maps of mosxe(^'°5) and mosxe . Oocytes miroinjected with the mosxe and MOs-(A'05) RNAs were in-
cubated in MBS-H containing ["Pjorthophosphate until mosxe-injected oocytes reached 100% GVBD. Note that the MOS-(A'05)-injected
oocytes did not undergo maturation . Thephosphorylated mos proteins were purified by immunoprecipitation with anti-mosxe serum and
12 .5% SDS-PAGE . The proteins were recovered from the gel and digested with chymotrypsin . The resultant phosphopeptides were sep-
arated onTLC plates by electrophoresis in the horizontal direction and by chromatography in the vertical direction, as indicated . In the
mixed sample, an approximately equal number of cpm from the mutant and wild type were used . x indicates the location of the origin .
Phosphopeptides were detected by autoradiography with an intensifying screen for 6 d.
mos" mutant
GVBD
Number of
oocytes
assays
GVBD CSF
activity
Chymotryptic
peptides
wild type 124 90 + wild type
A3 33 82 + missing No . 1
and No . 2
A16 33 85 + wild type
A18 33 91 + wild type
A25 32 91 + wild type
A26 36 97 + wild type
A57 33 88 + wild type
A71 35 86 + wild type
A76 37 84 + wild type
A102 35 91 + wild type
A105 90 0 - wild type
A 127 36 100 + wild type
A211 32 84 + wild type
A258 31 94 + wild typeFigure S. Chymotryptic phosphopeptide maps of mos'*^ 31 and mos- . Oocytes microinjected with the mos- and mos-W> RNAs were incu-
bated in MBS-H containing [32p]orthophosphate until the injected oocytes reached 100% GVBD. The phosphorylated mos proteins were
purified by immunoprecipitation with anti-mos' serum and 12.5% SDS-PAGE . The proteins were recovered from the gel and digested
with chymotrypsin . The resultant phosphopeptides were separated on TLC plates by electrophoresis in the horizontal direction and by
chromatography in the vertical direction, as indicated . In the mixed sample, an approximately equal number of cpm from the mutant and
wild type were used . x indicates the location of the origin . Phosphopeptides were detected by autoradiography with an intensifying screen
for 7 d .
maps shown in Fig . 2 . However, the yield of peptide No . 5
was very low, although it was faintly visible on all of the
original autoradiograms of the maps shown in Fig. 4 . The
variable yield of peptide No. 5 is most easily explained as
the consequence of chymotrypsin digestion at a secondary
cleavage site . The maps in Fig. 4 also contain an additional
labeled spot, No . 6, which is most likely because of con-
taminating [32p]orthophosphate. It is possible that the
chymotryptic peptide containing serine-105 was not resolved
or recovered using the conditions employed here. However,
this relatively hydrophilic chymotryptic peptide is predicted
to be the only peptide that is positively charged, even when
maximally phosphorylated . As further proof that serine-105
is not a major phosphorylation site, we found that tryptic
phosphopeptide maps of the mos-(A' 01) and mosx° proteins
were also identical (data not shown) .
Identification ofSerine-3 as aMajorSite
ofPhosphorylation
To identify the origin of the mos .° phosphopeptides, we
compared chymotryptic phosphopeptide maps of each mu-
tant to that of the wild-type protein . Only MOs-'A3) ex-
hibited a phosphorylation pattern different from that of
mos-, as shown in the maps presented in Fig . 5. The pep-
tide map of mosxa^ 3 ' lacked chymotryptic peptides No. 1
and No. 2, which were present in the map of wild-type
mos"° . Since the mutant and wild-type proteins differ by
only a single residue, we reasoned that peptides No . 1 and
No . 2 were likely to be related by containing serine-3 . The
predicted chymotryptic peptide containing serine-3 has the
sequence MPSPIPVERR The mobility of peptide No. 1 was
altered after redigestion with trypsin (data not shown), as ex-
pected if trypsin cleaves after the arginine residue in
chymotryptic peptide No . 1 . The mobility of peptide No. 2
was not altered after redigestion with trypsin (data not
shown), indicating that it arises from chymotrypsin cleavage
at a secondary site within peptide No. 1 . Since chymotrypsin
cleaves with a probability of4% after arginine (Keil, 1987),
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the most likely assignment of chymotryptic peptide No . 2 is
MPSPIPVER . This assignment is also consistent with the
relative mobilities of peptides No. 1 and No. 2 observed
here .
To prove that both chymotryptic peptides No. 1 and No.
2 contain serine-3, we redigested the two peptides with
proline-specific endopeptidase (Yoshimoto et al., 1980) . As
shown in Fig . 6, digestion ofeither chymotryptic peptideNo.
1(B) or peptideNo . 2 (F) yielded twonew phosphopeptides .
Mixing of the secondary digestion products from peptides
No . 1 and No. 2 revealed that the two sets of new peptides
(labeled with arrowheadsA andB) were identical (see panel
D) . Digestion of either chymotryptic peptideNo . 1 or 2 with
proline-specific endopeptidase should yield a peptide of the
sequence MP_SP, which most likely corresponds to peptide
B. If only partial digestion were obtained with proline-
specific peptidase, then both chymotryptic peptides No . 1 or
No . 2 would also yield a peptide of the sequence MP_SPIP,
which most likely corresponds to the peptide A . Note that
because proline-specific peptidase requires an amino acid at
the -3 position (Yoshimoto et al ., 1980), the cleavage prod-
ucts _SP or _SPIP are not expected .
The secondary digestions with proline-specific peptidase
clearly show that chymotryptic peptides No . 1 andNo . 2 are
related by a common sequence containing a phosphorylated
serine residue . The fact that both peptides No . 1 and No. 2
are absent from the chymotryptic peptide map of the
moxx°1^3> protein confirms that this phosphorylated serine is
in fact serine-3 .
Although these data clearly indicate that serine-3 is a ma-
jor phosphorylation site, mutation of this residue does not
affect the ability of mosx°'^3 > to induce oocyte maturation
(Table I) .
Cytostatic FactorActivity ofmos-
Serine-Alanine Mutants
The mos" protein has recently been identified as an essen-
tial component of cytostatic factor (Sagata et al ., 1989b), an
730Figure 6. Secondary digestion of chymotryptic peptides No . 1 and No . 2 . (A) Chymotryptic peptideNo. 1, undigested . (B) Chymotryptic
peptideNo. 1, digested with praline-specific endopeptidase. (C) Chymotryptic peptide No . 1, mix of undigested plus digested with proline-
specific endopeptidase . (D) Mix ofchymotryptic peptidesNo. 1 andNo . 2 each digested with proline-specific endopeptidase. (E) Chymo-
tryptic peptideNo . 2, undigested . (F) Chymotryptic peptideNo. 2, digested with proline-specific endopeptidase. (G) Chymotryptic peptide
No. 2, mix of undigested plus digested with proline-specific endopeptidase . Phosphopeptides corresponding to spots 1 and 2 in Fig . 5
were recovered from TLC plates and digested with proline-specific endopeptidase . The reaction products were then separated on TLC
plates by electrophoresis in the horizontal direction and chromatography in the vertical direction, as indicated . Mixed samples contain
an approximately equal number ofcpm from each individual digest. x indicates the location ofthe origin for each sample . Phosphopeptides
were detected by autoradiography with an intensifying screen for 10 d . Note that samples A, B, C, and D were spotted at intervals of
4 cm and analyzed together on one TLC plate . Samples E, F, and G were spotted at intervals of 5 cm and analyzed on a second TLC
plate . Because of the relatively high electrophoretic mobility of the proline peptidase products labeled with arrowheads A and B, these
peptides have moved leftward towards the origin ofthe adjacent map and, in some cases, have actually crossed over the origin . The dashed
lines have been drawn to indicate this. As described in the text, the most probable assignments for these peptides are : chymotryptic peptide
No . 1, MPSPIPVERF ; chymotryptic peptide No. 2, MPSPIPVER ; proline peptidase peptide A, MPSPIP ; proline peptidase peptide B,
MPSR An additional faint peptide may be seen above chymotryptic peptide No. 1 in some of the maps . This peptide appeared to arise
as a breakdown product from peptide No . 1 in repeated experiments and was not further characterized .
activity thought to be responsible for inducing metaphase ar-
rest at meiosis II in a mature egg (Meyerhof and Masui,
1979) . To test the serine-alanine mos- mutants for CSF
activity, we microinjected in vitro synthesized RNA encod-
ing wild-type mos- RNA, or RNAs encoding each of the
13 serine-alanine mutants . As shown in Table I, all but one
of the serine-alanine mutants inducedCSF arrest similar to
wild type. The mosxe(A)os) mutant failed to arrest cleavage of
injected blastomeres . A similar result was observed when
blastomeres were injected with RNA encoding the kinase-
inactive mutant mosxaR9o) . Representative photomicrographs
of embryos -4 h after microinjection are shown in Fig . 7.
Although varying extents of CSF were observed, as shown
in the two photomicrographs of embryos injected with wild-
type mosxe RNA, CSF arrest was reproducibly observed in
all cases except for the mosxe(R9o) mutant (Fig. 7, R90) and
the mosxe(A 1os) mutant (Fig . 7, A105) .
These results indicate that ofthe 13 most highly conserved
serine residues in mosxe, only serine-105 is essential for
CSF activity. Since serine-105 was also essential for the in-
duction of oocyte maturation, this indicates a complete
correlation in these mutants between induction of oocyte
maturation and CSF activity. In addition, these data indicate
that although serine-3 represents a major phosphorylation
site, phosphorylation at this residue is not required for the
CSF activity of mosxe .
Discussion
The mosxe protein kinase is phosphorylated during oocyte
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maturation . Moreover, hyperphosphorylated forms of the
mos- protein appear at or soon after GVBD (Watanabe et
al ., 1989; data not shown), as indicated by retarded elec-
trophoretic mobility onSDS-PAGE . After egg activation, the
mos- protein is first dephosphorylated and then rapidly
degraded (Watanabe et al ., 1989) . Together, these results
suggest the possibility that mosxe activity may be regulated
by phosphorylation .
In matured Xenopus eggs, the mos- protein constitutes
only "0.001% of the total soluble protein (Watanabe et al .,
1989) . Because of this low level of expression, we overex-
pressed the mosxe protein by microinjecting oocytes with in
vitro synthesized mosxe RNA . Microinjection of "100 ng of
mosxe RNA results in a 10-20-fold overexpression of the
protein relative to the endogenous level found in progester-
one matured oocytes (Sagata et al., 1989a ; Freeman et al.,
1990) . When analyzed by SDS-PAGE, the overexpressed
phosphorylated mosxe protein comigrates with the phos-
phorylated species of the endogenous mos- protein (data
not shown) . Thus, although we have been unable to recover
sufficient amounts of phosphorylated endogenous mosxe
protein for peptide mapping, it would appear that overex-
pressed mosxe protein is phosphorylated similarly to endog-
enous mosxe protein .
Phosphoamino acid analysis of the endogenous mosxe
protein from matured oocytes revealed only phosphoserine .
This is consistent with the phosphoamino acid content of the
v-mos protein isolated from mos-transformed NIH-3T3 cells
(Papkoff et al ., 1982) .
We have found that the kinase-inactive mosxem'°) proteinFigure 7 . Assays of mosxe mutants for CSF activity. CSF activity was assayedby . Jnicroinjection of in vitro synthesized RNA into cleaving
two-cell embryos . Photomicrographs of representative embryos are presented foreachoftheRNAs assayed. Additional experimental details
are contained in Materials and Methods and the legend to Table l . Bar, (R90) As a negative control, RNA encoding the kinase inactive
mosxe(R9 °) mutant was assayed, shown in theupper left photomicrograph . (wild type) As a positive control, RNAencoding wild-type mosxe
was assayed, shown in the middle two photomicrographs of the top row . These two photomicrographs were chosen to depict the range
of CSF arrest that was observed . This ranged from arrest at the two-cell stage, resulting in noncleavage of half of the embryo, to arrest
at the 16-32-cell stage, resulting in multiple large uncleaved blastomeres which are clearly visible . (A105) This wasthe only serala mutant
that was negative forCSF activity, as shown in theupper right photomicrograph . (Other serala mutants) Theremaining serala mutants
all displayed CSF activity, as shown in the three lower rows of photomicrographs . Bar, 1 mm .
is also phosphorylated on serine residues when expressed
in oocytes . Two-dimensional phosphopeptide maps of the
mosu(R9o) protein from resting oocytes and the mosxe(R 9o) pro-
tein from post-GVBD oocytes are essentially identical,
demonstrating that the major phosphopeptides do not result
from autophosphorylatinn . In addition, it is clear that the
hyperphosphorylation of mosxe at GVBD does not involve
additional phosphorylations at new sites . However, we can-
not rule out the possibility that the wild-type mosxe protein
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could phosphorylate itself at the same sites phosphorylated
on MOSWR9ol by otherprotein kinases. We have only recently
detected avery low level of in vitro autophosphorylating ac-
tivity in mosxe immune complexes from mature oocytes
consistent with the results ofYew et al . (1991) . However, due
to the inefficient labeling ofmosxe in vitro, we have not been
able to compare the peptide maps of the in vitro and in vivo
phosphorylated more proteins . We also cannot rule out the
possibility that a small amount of endogenous mosxe protein
732is present in immature oocytes and is able to phosphorylate
the mosxe(RVO) protein in trans; however, we (unpublished
data) and others (Sagata et al., 1989a; Watanabe et al.,
1989) have been unable to detect mope protein in oocytes
before progesterone treatment.
Our results suggest that all of the major phosphorylations
on mope are catalyzed by an unidentified protein kinase
which is active in immature oocytes. Since no new major
sites of phosphorylation are used during maturation, this
poses the question of why a slower electrophoretic species
of hyperphosphorylated mope should appear during oocyte
maturation. The most likely explanation would be an in-
crease in the stoichiometry of phosphorylation. For exam-
ple, molecules which are singly phosphorylated at either
serine-3 or an unidentified serine (corresponding to the
unidentified chymotryptic peptides No. 3 or No. 4) may be-
come doubly phosphorylated at two sites. However, since
mutation of serine-3 does not inactivate the ability of the
mosxe(AS) mutant to either induce oocyte maturationor func-
tion as CSF, the appearance of the hyperphosphorylated
mos- species most likely has little functional significance
except to reflect the overall increase in protein phosphoryla-
tion that accompanies oocyte maturation. A significant in-
crease in protein phosphorylation is known to occur in
maturing oocytes (Maller et al., 1977) and several proteins
have been shown to undergo maturation-specific phosphory-
lations (Lohka et al., 1987; Cicirelli et al., 1988; Cooper,
1989). It should be noted that since no quantitative assays
presently exist for mope protein kinase activity, we cannot
rule out the possibility that phosphorylation at serine-3 could
affect its specific activity, leading to quantitative rather than
qualitative effects on maturation induction or CSF activity.
In this work, we have found that all but one of the most
highly conserved serine residues within the various mos
proteins were dispensible for the maturation-inducing and
CSF activities of mos,e. However, the mosxe(Atos) mutant
was completely inactive in these biological assays. The
MOS-(A101) mutant protein was stably expressed and phos-
phorylated in microinjected oocytes. However, we did not
detect any differences in the phosphopeptide maps of the
MOS-(A105) protein compared with the wild-type mos- pro-
tein. It is likely that serine-105 is a structurally important
residue and not a site ofphosphorylation given its closeprox-
imity to a glutamate residue (glutamate-109) that is highly
conserved among known protein kinases (Hanks et al.,
1988). Work from another laboratory (Okazaki et al ., 1991)
has demonstrated that deletion of the NHZ-terminal 50
amino acids of more has no effect on either its maturation-
inducing or CSF activities. This is consistent with our results
that mutagenesis of the NHz-terminal serine residues S3,
S16, S18, S25, and S26, has no effect on the biological activ-
ity of mos"e.
This work identifies serine-3 as a major in vivo site of
phosphorylation. Serine-alanine mutagenesis at this resi-
due removes both chymotryptic peptides No. 1 and No. 2.
That both of these peptides contain serine-3 was shown by
secondary digestions with proline-specific peptidase which
yielded identical phosphopeptide products. We have not yet
identified the phosphorylated serine residue(s) responsible
for chymotryptic peptide No. 3 and No. 4. However, it is
clear that these phosphopeptides do not arise from phos-
phorylation at any of the 13 conserved serine residues exam-
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ined in this work. We would suggest that this additional
phosphorylation(s) is not likely to be of biological signifi-
cance. In this work, we have examined all serine residues
conserved in at leastthree out ofthe four species ofmos pro-
tein: Xenopus, chicken, human, and mouse. Other investiga-
tors have demonstrated that mos proteins from diverse or-
ganisms are biologically active in Xenopus oocytes (Yew et
al ., 1991). Thus the phosphorylation(s) giving rise to chy-
motryptic peptides No. 3 and No. 4 must be species-specific.
If this additional phosphorylation is of biological signifi-
cance, one would have to argue that a key regulatory site
used in Xenopus more is not conserved in the other mos
species even though they are also biologically active when
expressed in Xenopus oocytes.
On occasional peptide maps, a number of minor chymo-
tryptic phosphopeptides were observed, including the la-
beled peptide No. 5. The occurrence of minor phosphopep-
tides is best illustrated in the right hand map shown in Fig.
5. The yield of these minor peptides was variable and also
dependent upon excellent recovery of radio-labeled protein
throughout the peptide mapping procedure. Because of the
failure of proteases, especially chymotrypsin, to cleave with
absolute specificity, most of these minor phosphopeptides
probably represent partial or secondary digestion products.
For instance, several of the minor phosphopeptides are ab-
sent in the map of MOSxe(n9) (Fig. 5, left panel) and presum-
ably represent peptides containing serine-3. However, un-
likely though it seems, we cannot rule out the possibility that
one or more minor phosphopeptides may be biologically
significant.
One potential criticism ofour experimental approach con-
cerns the fact that endogenous more protein would have
been expressed and recovered together with any ofthe 12 bi-
ologically active serine-alanine mutant more proteins.
This couldhave been avoided by first microinjecting oocytes
with an antisense mope oligonucleotide to inhibit endoge-
nous mope expression (Sagata et al., 1988; Freeman et al.,
1990). For a number oftechnical reasons, including the large
numbers of oocytes required to recover sufficient radiola-
beled MOSxe protein for peptide mapping, we chose not to
attempt to eliminate endogenous mope expression in these
experiments. As discussed previously, microinjection of
RNA leads to expression of mutant mos- proteins at levels
10-20-fold compared with endogenous mope. This means
that in peptide maps of the biologically active serine-ala-
nine mope mutants a maximum of 5-10% of the recovered
protein may represent endogenous MOSxe protein. This level
ofcontamination would not affect any of the results reported
here.
The phosphorylation of the mope protein might regulate
its ability to induce CSF arrest. Previous studies demon-
strated that the half-life of the mope protein from matured
eggs is significantly greater than its half-life in pre-GVBD
oocytes (Watanabe et al., 1989) . In addition, there is evi-
dence that mope phosphorylation may be necessary to en-
hance or preserve CSF activity. During normal maturation,
CSF activity is detected only after GVBD, rising in conjunc-
tion with the transition into the second meiotic metaphase
(Meyerhof and Masui, 1979). In metaphase egg extracts,
CSF activity can be enhanced as well as sustained by the ad-
dition of phosphate inhibitors and ATP (Shibuya and Masui,
1988 ; Moses and Masui, 1990) . Interestingly, the MOSxeprotein in CSF extracts is also directly modified by these
agents; the abundance of MoSxe protein does not change but
the apparent molecular mass of the protein increases, pre-
sumably because of hyperphosphorylation (Sagata et al.,
19896). In the work reported here, we observed a strict
correlation between the ability of different serine-alanine
mutants to induce oocyte maturationand to function in CSF
assays. Taken together, these arguments strongly suggest that
phosphorylation is not involved in converting a pre-GVBD
CSF-inactive form of mose into a post-GVBD CSF-active
form. In this regard, it was recently shown that the overex-
pressed mosx° proteins from pre-GVBD oocytes and from
post-GVBD oocytes possess similar CSF activities (Kanki
and Donoghue, 1991), although such assays do not address
whether the MoSxe protein from pre-GVBD oocytes may
undergo additional phosphorylation in the injected blasto-
meres.
In addition to its other activities, it should be noted that
mos translation is required for progression from meiosis I to
meiosis II, both in Xenopus oocytes (Kanki and Donoghue,
1991) and murine oocytes (O'Keefe et al., 1989) . For techni-
cal reasons, the work presented in this study has not ad-
dressed whether phosphorylation of mos protein (possibly
even at serine-3) may be required for its activity to promote
progression from meiosis I to meiosis II.
There are five serine-proline motifs present in MoSxe that
could act as potential sites of p34c'~z phosphorylation, al-
though none of these fit the more rigorous Ser-Pro-X-
Lys/Arg consensus sequence (Moreno and Nurse, 1990).
Three of these serines (S3, S16, and S26) were mutated in
this study and found not to be required for the maturation
inducing or CSF activities of mosxe. We have demonstrated
that serine-3 is a major phosphorylation site in more. How-
ever, it seems unlikely that this residue is phosphorylated in
vivo by p34e°ez since phosphorylation of this site occurs in
both the mosxe(R90) and mosxe(Aios) mutants that fail to induce
oocyte maturation or activate MPF.
It has long been a matter of speculation whether phos-
phorylation may regulate the activity of more with respect
to the initiation of meiotic maturation or its ability to func-
tion as CSR Our results indicate that significant phosphory-
lation at unique sites in the more protein does not occur
during maturation and are not likely to be catalyzed by
p34c°ez. In addition, the major phosphorylations of mosse
can occur in the absence of autophosphorylation. Finally,
phosphorylation of conserved serine residues does not ap-
pear to regulate the ability of MOSxe to induce oocyte matu-
ration or function as CSF.
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